Replies to post #179969 on Biotech Values

[jq1234]

>> Transcept stockholders will retain their existing equity in Transcept for an aggregate ownership stake of approximately 10.4 percent.

At current stock price of $2.6, $50m market cap for TSPT, 10.4% ownership of combined company implies combined company is valued at $500m. Am I missing something?